Dr Reddys Inks commercialisation Deal with Hatchtech
Dr Reddy’s Laboratories has announced the signing of a commercialisation deal with Hatchtech, an Australian pharmaceutical company for developing an […]
Say something
Tags: Australia, BSE Sensex, Business Partnership, Business/Finance, Canada, Clinical Research, Dr. Reddy's Laboratories, Drug safety, FDA Phase, food and drug administration, Hatchtech, Health/Medical/Pharmaceuticals, India, lice infestation, medicine, New Drug Application, new zealand, Pediculosis capitis, pharmaceutical, Pharmaceutical industry, Pharmaceutical sciences, Pharmacology, prescription head lice product, PROMIUS PHARMA LLC, russia, United States, US Food and Drug Administration, USD, Venezuela, Xeglyze Lotion
-
-
Flipkart Health+ App Launched
06-04-2022
